Larvol Delta - Phase-I-trial-of-MEDI3726-a-prostatespecific-membrane-antigentargeted-antibodydrug-conjugate-in-patients-with-mCRPC-after-failure-of-abiraterone-or-enzalutamide

MEDI3726 - ADC Therapeutics, AstraZeneca

Xtandi (enzalutamide) - Pfizer, Astellas, Bausch Health

abiraterone acetate - Generic mfg.

http://www.ncbi.nlm.nih.gov/pubmed/33795255

Apr 7, 2021

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next